• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » OpenClinica, Athena partner to provide clinical trial support in China

OpenClinica, Athena partner to provide clinical trial support in China

August 25, 2011
CenterWatch Staff

OpenClinica has entered into a strategic alliance with Athena Healthcare Consultancy to bring the OpenClinica clinical trials software to the Chinese market. Headquartered in Shanghai, Athena will be the exclusive distributor of the OpenClinica enterprise edition and provide localized support and services for contract research organizations, pharmaceutical companies, and scientific institutes operating in China, according to Digital Journal.

As the world’s fastest growing clinical trial software, OpenClinica provides web-based electronic data capture and clinical data management functions that are increasingly critical to conducting efficient clinical trials in today’s highly regulated research environments.

Ben Baumann, OpenClinica’s director of business development, says “For the past 6 years OpenClinica has been used in FDA regulated clinical trials. We are excited to bring this world-class technology to China, which is increasing its standards for clinical research.”

While China has its own rapidly growing biopharmaceuticals industry, global clinical trial sponsors are increasing their amount of research being conducted in China. Improving regulations, a large patient population, and capable and motivated investigators are some of the factors that make China an increasingly appealing place to conduct research.

Athena Healthcare Consultancy general manager Ivan Tjong-A-Hung, MD says, “This alliance will allow us to better support China’s growing pharmaceutical and biotech research industries with a complete, fully localized solution for running clinical trials more productivity and according to global standard good clinical practices.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing